{"id":169494,"date":"2024-06-03T02:37:26","date_gmt":"2024-06-03T06:37:26","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/preliminary-analysis-of-data-evaluating-investigational-epcoritamab-duobody-cd3xcd20-combination-demonstrates-95-overall-response-rate-in\/"},"modified":"2024-08-18T11:48:28","modified_gmt":"2024-08-18T15:48:28","slug":"preliminary-analysis-of-data-evaluating-investigational-epcoritamab-duobody-cd3xcd20-combination-demonstrates-95-overall-response-rate-in","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/preliminary-analysis-of-data-evaluating-investigational-epcoritamab-duobody-cd3xcd20-combination-demonstrates-95-overall-response-rate-in.php","title":{"rendered":"Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody\u00ae CD3xCD20) Combination Demonstrates 95% Overall Response Rate in&#8230;"},"content":{"rendered":"<p><![CDATA[Media Release]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/06\/02\/2891863\/0\/en\/Preliminary-Analysis-of-Data-Evaluating-Investigational-Epcoritamab-DuoBody-CD3xCD20-Combination-Demonstrates-95-Overall-Response-Rate-in-Patients-with-Previously-Untreated-Follicu.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody\u00ae CD3xCD20) Combination Demonstrates 95% Overall Response Rate in...\">Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody\u00ae CD3xCD20) Combination Demonstrates 95% Overall Response Rate in...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody\u00ae CD3xCD20) Combination Demonstrates 95% Overall Response Rate in... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/preliminary-analysis-of-data-evaluating-investigational-epcoritamab-duobody-cd3xcd20-combination-demonstrates-95-overall-response-rate-in.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-169494","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169494"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169494"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169494\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}